News Silence Therapeutics plc

Equities

SLN

US82686Q1013

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
20.6 ^USD	-2.69%		+13.12%	+18.60%

Jul. 12	European Equities Traded in the US as American Depositary Receipts Climb Higher in Friday Trading	MT
Jul. 08	European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Climb Higher in Friday Trading	Jul. 12	MT
European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading	Jul. 08	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	Jul. 02	MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading	Jun. 28	MT
Chardan Raises Price Target on Silence Therapeutics to $55 From $42, Maintains Buy Rating	Jun. 28	MT
Morgan Stanley Raises Price Target on Silence Therapeutics to $49 From $45, Keeps Overweight Rating	Jun. 28	MT
Sector Update: Health Care Stocks Decline in Afternoon Trading	Jun. 27	MT
European Equities Close Mostly Lower Thursday; Bank of England Warns of 'Sharp Correction' Risk	Jun. 27	MT
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	Jun. 27	MT
Silence Therapeutics Says Divesiran Shows Sustained Hematocrit Reduction in Blood Cancer Study	Jun. 27	MT
Transcript : Silence Therapeutics plc - Special Call	Jun. 27
Silence Therapeutics Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients	Jun. 27	BU
Silence Therapeutics plc Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients	Jun. 27	CI
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Jun. 26	MT
Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration	Jun. 24	BU
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher	Jun. 21	MT
Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)	Jun. 20	BU
Silence Therapeutics plc Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(A)	Jun. 20	CI
Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading	Jun. 17	MT
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading	Jun. 12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Silence Therapeutics plc

Equities

SLN

US82686Q1013

Summary

Filters